Dear Colleague Letter: Xylazine

Communicating for Impact

Apr 11

Written By Jalyn Burns

The DEA recently issued a warning about xylazine, a veterinary drug. This "Dear Colleague" letter from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides a report on the risks of xylazine.

Source: Substance Abuse and Mental Health Services Administration (SAMHSA)

harm reductioncliniciansguidehealth carepolysubstance useweb page

Jalyn Burns

Harm Reduction Hacks Microsite

Fact Sheet: California Law and Syringe Services Programs